Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Other Working Capital Changes (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Other Working Capital Changes data on record, last reported at $514000.0 in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 183.58% year-over-year to $514000.0; the TTM value through Dec 2025 reached -$134000.0, down 107.85%, while the annual FY2025 figure was -$134000.0, 107.85% down from the prior year.
  • Other Working Capital Changes reached $514000.0 in Q4 2025 per TLSI's latest filing, up from -$567000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.5 million in Q3 2024 and bottomed at -$1.1 million in Q3 2023.
  • Average Other Working Capital Changes over 4 years is $195875.0, with a median of -$27062.5 recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: soared 1294.85% in 2023, then tumbled 6933.33% in 2024.
  • A 4-year view of Other Working Capital Changes shows it stood at $1.3 million in 2022, then plummeted by 99.3% to $9000.0 in 2023, then crashed by 6933.33% to -$615000.0 in 2024, then surged by 183.58% to $514000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $514000.0 in Q4 2025, -$567000.0 in Q3 2025, and -$25000.0 in Q2 2025.